Akoya Biosciences Inc. (AKYA) Prices 6.58M Share IPO at $20/Sh
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580,000 shares of its common stock at a price of $20.00 per share, for gross proceeds of $131.6 million, before underwriting discounts and commissions and offering expenses payable by Akoya. Akoya has also granted the underwriters a 30-day option to purchase up to an additional 987,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. All shares are being offered and sold by Akoya. The shares are expected to begin trading on the Nasdaq Global Select Market on April 16, 2021 under the ticker symbol “AKYA.” The offering is expected to close on April 20, 2021, subject to the satisfaction of customary closing conditions.
J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Piper Sandler &Co., and Canaccord Genuity LLC are acting as Joint Book-Running Managers for the offering.
The offering is being made only by means of a prospectus.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orion Biotech Opportunities Corp. (ORIA) Prices 20M Unit IPO at $10/Unit
- Genworth Financial (GNW) Postpones Planned IPO of Enact
- Ikena Oncology Reports First Quarter 2021 Financial Results and Outlines Key Corporate Objectives for 2021
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings, IPOs
Related EntitiesJPMorgan, Morgan Stanley, Canaccord Genuity, IPO
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!